Research ArticleLaboratory Studies
Pretargeted Immunoscintigraphy: Effect of Hapten Valency on Murine Tumor Uptake
David A. Goodwin, Claude F. Meares, Maureen McTigue, Warak Chaovapong, Carol I. Diamanti, Charles H. Ransone and Michael J. McCall
Journal of Nuclear Medicine November 1992, 33 (11) 2006-2013;
David A. Goodwin
Claude F. Meares
Maureen McTigue
Warak Chaovapong
Carol I. Diamanti
Charles H. Ransone


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Pretargeted Immunoscintigraphy: Effect of Hapten Valency on Murine Tumor Uptake
David A. Goodwin, Claude F. Meares, Maureen McTigue, Warak Chaovapong, Carol I. Diamanti, Charles H. Ransone, Michael J. McCall
Journal of Nuclear Medicine Nov 1992, 33 (11) 2006-2013;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Multifunctional Antibodies by the Dock-and-Lock Method for Improved Cancer Imaging and Therapy by Pretargeting
- Antibody Pretargeting Advances Cancer Radioimmunodetection and Radioimmunotherapy
- Improving the Delivery of Radionuclides for Imaging and Therapy of Cancer Using Pretargeting Methods
- Reagents and Methods for PET Using Bispecific Antibody Pretargeting and 68Ga-Radiolabeled Bivalent Hapten-Peptide-Chelate Conjugates
- A Universal Pretargeting System for Cancer Detection and Therapy Using Bispecific Antibody
- Molecular Advances in Pretargeting Radioimunotherapy with Bispecific Antibodies
- Pretargeting of Renal Cell Carcinoma: Improved Tumor Targeting with a Bivalent Chelate